Cassidy To FDA: It’s Your Job, Not FTC’s, To Clarify Orange Book Listings For Combo Products

By Maaisha Osman, Jessica Karins / October 1, 2024 at 7:14 PM

The Senate health committee’s top Republican says the Federal Trade Commission (FTC) has exceeded its authority by trying to eliminate "junk" patent listings in FDA's Orange Book, and he demands FDA clarify patent listings for drug-device combination products rather than leaving the responsibility to FTC.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.